benralizumab

This page shows the latest benralizumab news and features for those working in and with pharma, biotech and healthcare.

Novartis strengthens case for its combination asthma drug

as AstraZeneca’s asthma injection Fasenra(benralizumab).

Nucala works in rare inflammatory disease, says GSK

GSK is trying to keep the first-to-market IL-5 inhibitor ahead of other drugs in the class, particularly AstraZeneca’s Fasenra (benralizumab) which is gaining ground fast with
Tecentriq’s triple negative breast cancer use among key CHMP nods

The company also received a positive opinion for a new self-administration option for Fasenra (benralizumab) via a pre-filled, single-use auto-injector, rivalling similar moves from GSK and its
GSK’s Nucala gets boost with self-administration approval

Fasenra (benralizumab) and Teva’s Cinqair/Cinqaero (reslizumab).
AZ says dropping MedImmune will help ‘streamline’ its R&D

The Gaithersburg, Maryland-headquartered company is the source of a chunk of AZ’s biologics pipeline, including cancer immunotherapy Imfinzi (durvalumab) and severe asthma drug Fasenra (benralizumab) that were both highlighted
Cancer drugs and China sustain AZ’s return to growth

Among these, severe asthma therapy Fasenra (benralizumab) shrugged off a tough competitive environment to post $297m in sales in its first full-year on the market despite going toe-to-toe

More from news
Approximately 8 fully matching, plus 41 partially matching documents found.

Deal Watch March 2017

In order to focus its respiratory resources on products such as Symbicort and benralizumab, AstraZeneca has agreed that its product Tudorza (marketed for COPD) and Duaklir (in phase III for COPD)
Pharma deals in July 2015

In Japan, AZ paid $45m for an option with Kyowa Hakko Kirin to commercialise benralizumab (currently in phase III for treatment of severe uncontrolled asthma and COPD) in Japan.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Senior Medical Writer – Leading Medical Communications Agency – ...: Highly Competitive Remuneration Package

Scientific Director - Medical Education - Cheshire & London ...: Excellent Remuneration Package

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Senior / Principal Medical Writer – Medical Education - UK &...: Excellent Salary and Benefits on offer

Graduate / Entry Level Opportunities – Medical Communications – ...: Highly Competitive Remuneration Package

Experienced / Senior Medical Writer - MedComms - Cardiff - Wales: Excellent Salary and Benefits on offer

Scientific Director - Medical Communications Agency - New York: Excellent Remuneration Package

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Add my company

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

The 2019 CPhI Pharma Index Report: Examining this year’s industry performance...
Five key trends in precision and personalised healthcare: Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications: Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...